Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study

NCT06118749 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.

NCT NCT06118749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06118749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
Lead sponsor
Foundation for Innovative New Diagnostics, Switzerland
Phase
Observational
Overall status
Terminated
Start date
December 20, 2023
Completion date
July 31, 2024
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

visceral leishmaniasis